{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:29:12Z","timestamp":1787797752221,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,1,9]],"date-time":"2008-01-09T00:00:00Z","timestamp":1199836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s12032-007-9038-7","type":"journal-article","created":{"date-parts":[[2008,1,8]],"date-time":"2008-01-08T15:30:17Z","timestamp":1199806217000},"page":"315-322","source":"Crossref","is-referenced-by-count":19,"title":["Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters"],"prefix":"10.1007","volume":"25","author":[{"given":"Vladimir","family":"Jurisic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Colovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Kraguljac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Dushan","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Colovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,9]]},"reference":[{"key":"9038_CR1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","volume":"48","author":"JL Binet","year":"1981","unstructured":"Binet JL, Auquier A, Dighiero G, et\u00a0al. A new prognostic classification of chronic lymphocytic leukaemia derived from a multivariate survival analysis. Cancer 1981;48:198\u2013206.","journal-title":"Cancer"},{"key":"9038_CR2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP, et\u00a0al. Clinical staging of chronic lymphocytic leukaemia. Blood 1975;46:219\u201334.","journal-title":"Blood"},{"key":"9038_CR3","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1182\/blood.V99.11.4087","volume":"99","author":"RN Damle","year":"2002","unstructured":"Damle RN, Fhiotto F, Valetto A, Albesiano E, Fais F, Yan XJ, Sison CP, Allen SL, Kollitz J, Schulman P, Vinciquerra VP, Budde P, Frey J, Rai KR, Feranini M, Chiorazzi N. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated antigen experienced B lymphocyte. Blood 2002;99:4087\u201393.","journal-title":"Blood"},{"key":"9038_CR4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jcp.42.6.567","volume":"42","author":"JM Bennett","year":"1989","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid leukemias. French-American-British (FAB) Cooperative Group. J Clin Pathol 1989;42:567\u201384.","journal-title":"J Clin Pathol"},{"key":"9038_CR5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1365-2141.1996.d01-1478.x","volume":"92","author":"E Matutes","year":"1996","unstructured":"Matutes E, Oscier D, Garcia-Marco J, et\u00a0al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996;92:382\u20138.","journal-title":"Br J Haematol"},{"key":"9038_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0090-1229(89)90192-X","volume":"52","author":"LA Landay","year":"1989","unstructured":"Landay LA, Muirhead KA. Procedural guidelines for performing immunophenotyping by flow cytometry. Clin Immunol Immunopathol 1989;52:48\u201360.","journal-title":"Clin Immunol Immunopathol"},{"key":"9038_CR7","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.V78.7.1795.1795","volume":"78","author":"CH Geisler","year":"1991","unstructured":"Geisler CH, Larsen JK, Hansen NE, et\u00a0al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991;78:1795\u2013802.","journal-title":"Blood"},{"key":"9038_CR8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0609.1989.tb00335.x","volume":"4","author":"E Kimby","year":"1989","unstructured":"Kimby E, Mellstedt H, Bjorkholm M, Holm G. Clonal cell surface structure related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of unknown significance. Eur J Haematol 1989;4:452\u20139.","journal-title":"Eur J Haematol"},{"key":"9038_CR9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.leu.2401636","volume":"14","author":"E Klein","year":"2000","unstructured":"Klein E, Miera O, Bauer O, et\u00a0al. Chemosensitivity of B cell chronic lymphocytic leukaemia and correlated expression of protein regulating apoptosis, cell cycle and DNA repair. Leukaemia 2000;14:40\u20136.","journal-title":"Leukaemia"},{"key":"9038_CR10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/eji.1830210504","volume":"21","author":"YJ Liu","year":"1991","unstructured":"Liu YJ, Cairns JA, Holder MJ, Abbot SD, Jansen KU, Bonnefoy JY, Gordon J, MacLennan ICM. Recombinant 25-kDa CD23 and interleukin 1\u03b1 promote the survival of germinal centre B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 1991;21:1107\u201314.","journal-title":"Eur J Immunol"},{"key":"9038_CR11","first-page":"591","volume":"19","author":"M Sarfati","year":"1993","unstructured":"Sarfati M. CD23 and chronic lymphocytic leukemia. Blood Cells 1993;19:591\u20136.","journal-title":"Blood Cells"},{"key":"9038_CR12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2141.1988.tb04203.x","volume":"68","author":"R Dadmarz","year":"1988","unstructured":"Dadmarz R, Cawley JC. Heterogeneity of CLL: high CD23 antigen and \u03b1 IFN receptor expression are features of favourable disease and cell activation. Br J Haematol 1988;68:279\u201382.","journal-title":"Br J Haematol"},{"key":"9038_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0145-2126(90)90145-Y","volume":"14","author":"M Sarfati","year":"1990","unstructured":"Sarfati M, Founier S, Christoffersen C, Biron G. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. Leukemia Res 1990;14:47\u201355.","journal-title":"Leukemia Res"},{"key":"9038_CR14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1182\/blood.V71.1.94.94","volume":"71","author":"M Sarfati","year":"1988","unstructured":"Sarfati M, Born D, Lagneaux L, Fonteyn C, Frost H, Delespesse G. Evaluation of IgE-Binding factors in serum of patients with B cell derived chronic lymphocytic leukemia. Blood 1988;71:94\u20138.","journal-title":"Blood"},{"key":"9038_CR15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2141.1989.tb04336.x","volume":"72","author":"J Gibson","year":"1989","unstructured":"Gibson J, Neville S, Joshua D, Kroninberg H. CD23 antigen expression in CLL. Br J Haematol 1989;72:598\u2013663.","journal-title":"Br J Haematol"},{"key":"9038_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02592696","volume":"34","author":"F Vinante","year":"1995","unstructured":"Vinante F, Vassanelli A, Zanotti R, et\u00a0al. Circulating levels of soluble CD23 reflects clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders. Int J Clin Lab Res 1995;34:189\u201394.","journal-title":"Int J Clin Lab Res"},{"key":"9038_CR17","first-page":"428","volume":"81","author":"S Molica","year":"1996","unstructured":"Molica S, Levato D, Dell\u2019Olio M, Minervini M, Dattilo A, Carotenuto M, Musto P. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukaemia. Implications for prognosis. Haematologica 1996;81:428\u201333.","journal-title":"Haematologica"},{"key":"9038_CR18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0145-2126(91)90030-W","volume":"15","author":"S Fournier","year":"1991","unstructured":"Fournier S, Tran ID, Suter U, Biron G, Delespesse G, Sarfati M. The in\u00a0vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts. Leukaemia Res 1991;15:609\u201318.","journal-title":"Leukaemia Res"},{"key":"9038_CR19","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood.V84.6.1881.1881","volume":"84","author":"S Fournier","year":"1994","unstructured":"Fournier S, Rubio M, Delespesse G, Sarfati M. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood 1994;84:1881\u20136.","journal-title":"Blood"},{"key":"9038_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.1995.tb03314.x","volume":"89","author":"S Fournier","year":"1995","unstructured":"Fournier S, Yang LP, Delespesse G, Rubio M, Biron G, Sarfati M. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia. Br J Heamatol 1995;89:373\u20139.","journal-title":"Br J Heamatol"},{"key":"9038_CR21","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood.V99.10.3742","volume":"99","author":"R Hubmann","year":"2002","unstructured":"Hubmann R, Schwarzmeier DJ, Shenata M, Hilgart M, Duechler M, Dettke M, Buerger R. Notch 2 is involved in the overexpression of CD23 in-B-cell chronic lymphocytic leukemia. Blood 2002;99:3742\u20137.","journal-title":"Blood"},{"key":"9038_CR22","first-page":"8","volume":"13","author":"T Lavabre-Bertrand","year":"1994","unstructured":"Lavabre-Bertrand T, Exbrayat C, Bourquard P, Lavabre-Bertrand C, Feregueux N, Poncelet P, Rousset T, Taib J, Emberger JM, Navarro M. CD23 antigen density is related to serum gamma globulin level, bone marrow reticulin pattern, and treatment in B chronic lymphocytic leukaemia. Leukemia Lymph 1994;13:8\u201394.","journal-title":"Leukemia Lymph"},{"key":"9038_CR23","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1172\/JCI115717","volume":"89","author":"S Fournier","year":"1992","unstructured":"Fournier S, Delespesse G, Rubio M, Biron G, Sarfati M. CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J Clin Invest 1992;89:1312\u201321.","journal-title":"J Clin Invest"},{"key":"9038_CR24","first-page":"1732","volume":"93","author":"S Molica","year":"1999","unstructured":"Molica S, Levato D, Cascavilla N, et\u00a0al. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and \u03b22-microglobulin in B-cell chronic lymphocytic leukaemia. Eur J Haematol 1999;93:1732\u20137.","journal-title":"Eur J Haematol"},{"key":"9038_CR25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1309\/MFCP-7GMW-AQM4-ED3N","volume":"114","author":"N Kraguljac","year":"2000","unstructured":"Kraguljac N, Marisavljevic D, Jankovic G, Radosevic N, Pantic M, Donfrid M, Miletic N, Boskovic D, Colovic M. Characterisation of CD13 and CD33 surface antigen-negative acute myeloid leukemia. Am J Clin Pathol 2000;114:29\u201334.","journal-title":"Am J Clin Pathol"},{"key":"9038_CR26","first-page":"1640","volume":"8","author":"E Matutes","year":"1994","unstructured":"Matutes E, Owusu-Ankomah K, Morilla R, Garci Marco H, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640\u20135.","journal-title":"Leukemia"},{"key":"9038_CR27","first-page":"1140","volume":"85","author":"M Lopez-Matas","year":"2000","unstructured":"Lopez-Matas M, Rodriquez-Justo M, Morilla R, Catovksy D, Matutes E. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia. Haematologica 2000;85:1140\u20135.","journal-title":"Haematologica"},{"key":"9038_CR28","first-page":"326","volume":"7","author":"DM Dorfman","year":"1994","unstructured":"Dorfman DM, Pinkus GS. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Modern Pathol 1994;7:326\u201331.","journal-title":"Modern Pathol"},{"key":"9038_CR29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/ajcp\/105.4.451","volume":"105","author":"MN Kilo","year":"1996","unstructured":"Kilo MN, Dorfman DM. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma\/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol 1996;105:451\u20137.","journal-title":"Am J Clin Pathol"},{"key":"9038_CR30","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","volume":"102","author":"F Fais","year":"1998","unstructured":"Fais F, Ghiotto F, Hashimoto S. Chronic lymphocytic leukemia B cell express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515\u201325.","journal-title":"J Clin Invest"},{"key":"9038_CR31","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Davis Z, Gardliner A, Oscier DG, Stevenson FK. Unmutated IgV genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;1848\u201354.","DOI":"10.1182\/blood.V94.6.1848.418k05_1848_1854"},{"key":"9038_CR32","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1007\/s001090050351","volume":"77","author":"G Meinhardt","year":"1999","unstructured":"Meinhardt G, Wendtner CM, Hallek M. Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell grow and survival. J Mol Med 1999;77:3379\u201389.","journal-title":"J Mol Med"},{"key":"9038_CR33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0301-472X(02)01076-7","volume":"31","author":"C Bogner","year":"2003","unstructured":"Bogner C, Schneller F, Hipp S, Ringshausen I, Peschel C, Decker T. Cyclin B-CLL are highly susceptible to inhibition of the proteosome: involvement of p27, early D-type cyclin, Bax, and caspase-dependent and independent pathways. Exp Hematol 2003;31:218\u201325.","journal-title":"Exp Hematol"},{"key":"9038_CR34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1385\/MO:19:3:133","volume":"19","author":"V Jurisic","year":"2002","unstructured":"Jurisic V, Colovic M. Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta-2 microglobulin, and clinical stage in multiple myeloma. Med Oncol 2002;19:133\u20139.","journal-title":"Med Oncol"},{"issue":"1","key":"9038_CR35","first-page":"25","volume":"52","author":"V Jurisic","year":"2005","unstructured":"Jurisic V, Kraguljac N, Konjevic G, Spuzic I. TNF-alpha induced changes in cell membrane expression on K-562 cells associated with increased lactate dehydrogenase (LDH) release. Neoplasma 2005;52(1):25\u201331.","journal-title":"Neoplasma"},{"key":"9038_CR36","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood.V91.10.3574","volume":"91","author":"K Warzoche","year":"1998","unstructured":"Warzoche K, Ribeino P, Bienvenue J, Roj P, Chrlot C, Rigal D, Coiifier B, Salles G. Genetic polymorphism in the tumor necrosis factor locus influence non-Hodgkin\u2019s lymphoma outcome. Blood 1998;91:3574\u201381.","journal-title":"Blood"},{"key":"9038_CR37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2141.1999.01738.x","volume":"107","author":"M Bernard","year":"1999","unstructured":"Bernard M, Drenou B, Pangault C, et\u00a0al. Spontaneous phenotypic and molecular blood remission in a case of chronic lymphocytic leukaemia. Br J Haematol 1999;107:213\u20134.","journal-title":"Br J Haematol"},{"key":"9038_CR38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/10428199709058320","volume":"27","author":"WU Knauf","year":"1997","unstructured":"Knauf WU, Langenmayer I, Ehlers B, et\u00a0al. Serum levels of soluble CD23 but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia. Leukemia Lymph 1997;27:523\u201332.","journal-title":"Leukemia Lymph"},{"key":"9038_CR39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0145-2126(02)00007-3","volume":"6","author":"ME Goller","year":"2002","unstructured":"Goller ME, Kneitz C, Mehringer C, Muller K, Jelley-Gibbs DM, Gosselin EJ, Wilhelm M, Hans-Peter T. Regulation of CD23 isoforms on B-chronic lymphocytic leukemia. Leukemia Res 2002;6:795\u2013802.","journal-title":"Leukemia Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-9038-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-007-9038-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-9038-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T03:22:39Z","timestamp":1708485759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-007-9038-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["9038"],"URL":"https:\/\/doi.org\/10.1007\/s12032-007-9038-7","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,9]]}}}